Matricelf Ltd

Tel Aviv Stock Exchange MTLF.TA

Matricelf Ltd EBIT for the year ending December 31, 2022: USD -3.50 M

Matricelf Ltd EBIT is USD -3.50 M for the year ending December 31, 2022, a 32.48% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • Matricelf Ltd EBIT for the year ending December 31, 2021 was USD -5.19 M, a -292.69% change year over year.
  • Matricelf Ltd EBIT for the year ending December 31, 2020 was USD -1.32 M, a -202.65% change year over year.
  • Matricelf Ltd EBIT for the year ending December 31, 2019 was USD -436.39 K.
Key data
Date EBIT EBITDA Net Income EPS (Diluted)
Market news
SV Wall Street
Tel Aviv Stock Exchange: MTLF.TA

Matricelf Ltd

CEO Mr. Alon Sinai
IPO Date June 21, 2021
Location Israel
Headquarters Golda Meir 3
Employees 13
Sector Healthcare
Industries
Biotechnology 3D Printing Medical Instruments Pharmaceuticals Robotics
Description

Matricelf Ltd, a biotechnology company, develops a platform for autologous matrix and cells implants for various medical conditions. Its regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D organ printing. Matricelf Ltd was founded in 2019 and is based in Ness Ziona, Israel.

StockViz Staff

February 6, 2025

Any question? Send us an email